181 related articles for article (PubMed ID: 33153232)
1. Inhibition of Src Family Kinases Ameliorates LPS-Induced Acute Kidney Injury and Mitochondrial Dysfunction in Mice.
Pak ES; Uddin MJ; Ha H
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153232
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological inhibition of Src kinase protects against acute kidney injury in a murine model of renal ischemia/reperfusion.
Xiong C; Zang X; Zhou X; Liu L; Masucci MV; Tang J; Li X; Liu N; Bayliss G; Zhao TC; Zhuang S
Oncotarget; 2017 May; 8(19):31238-31253. PubMed ID: 28415724
[TBL] [Abstract][Full Text] [Related]
3. UCP2 ameliorates mitochondrial dysfunction, inflammation, and oxidative stress in lipopolysaccharide-induced acute kidney injury.
Ding Y; Zheng Y; Huang J; Peng W; Chen X; Kang X; Zeng Q
Int Immunopharmacol; 2019 Jun; 71():336-349. PubMed ID: 30952098
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
[TBL] [Abstract][Full Text] [Related]
5. CO-Releasing Molecule-2 Prevents Acute Kidney Injury through Suppression of ROS-Fyn-ER Stress Signaling in Mouse Model.
Uddin MJ; Jeong J; Pak ES; Ha H
Oxid Med Cell Longev; 2021; 2021():9947772. PubMed ID: 34326922
[TBL] [Abstract][Full Text] [Related]
6. Pan-Src kinase inhibitor treatment attenuates diabetic kidney injury via inhibition of Fyn kinase-mediated endoplasmic reticulum stress.
Dorotea D; Jiang S; Pak ES; Son JB; Choi HG; Ahn SM; Ha H
Exp Mol Med; 2022 Aug; 54(8):1086-1097. PubMed ID: 35918533
[TBL] [Abstract][Full Text] [Related]
7. Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice.
Ren Q; Guo F; Tao S; Huang R; Ma L; Fu P
Biomed Pharmacother; 2020 Feb; 122():109772. PubMed ID: 31918290
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment with Rho-kinase inhibitor ameliorates lethal endotoxemia-induced liver injury by improving mitochondrial function.
Ding R; Han J; Zhao D; Hu Z; Ma X
Int Immunopharmacol; 2016 Nov; 40():125-130. PubMed ID: 27588912
[TBL] [Abstract][Full Text] [Related]
9. The role of the Src family of tyrosine kinases after oxidant-induced lung injury in vivo.
Khadaroo RG; He R; Parodo J; Powers KA; Marshall JC; Kapus A; Rotstein OD
Surgery; 2004 Aug; 136(2):483-8. PubMed ID: 15300219
[TBL] [Abstract][Full Text] [Related]
10. Oxidant-induced priming of the macrophage involves activation of p38 mitogen-activated protein kinase through an Src-dependent pathway.
Khadaroo RG; Parodo J; Powers KA; Papia G; Marshall JC; Kapus A; Rotstein OD
Surgery; 2003 Aug; 134(2):242-6. PubMed ID: 12947324
[TBL] [Abstract][Full Text] [Related]
11. UCP2-dependent improvement of mitochondrial dynamics protects against acute kidney injury.
Qin N; Cai T; Ke Q; Yuan Q; Luo J; Mao X; Jiang L; Cao H; Wen P; Zen K; Zhou Y; Yang J
J Pathol; 2019 Mar; 247(3):392-405. PubMed ID: 30426490
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Src family tyrosine kinases prevents lipopolysaccharide-induced hyporeactivity in isolated rat tail arteries.
Kox M; Wijetunge S; Pickkers P; Hughes AD
Vascul Pharmacol; 2007 Mar; 46(3):195-200. PubMed ID: 17113356
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D receptor activation protects against lipopolysaccharide-induced acute kidney injury through suppression of tubular cell apoptosis.
Du J; Jiang S; Hu Z; Tang S; Sun Y; He J; Li Z; Yi B; Wang J; Zhang H; Li YC
Am J Physiol Renal Physiol; 2019 May; 316(5):F1068-F1077. PubMed ID: 30864841
[TBL] [Abstract][Full Text] [Related]
14. Differential effects on cell motility, embryonic stem cell self-renewal and senescence by diverse Src kinase family inhibitors.
Tamm C; Galitó SP; Annerén C
Exp Cell Res; 2012 Feb; 318(4):336-49. PubMed ID: 22197704
[TBL] [Abstract][Full Text] [Related]
15. Src Family Kinases: A Potential Therapeutic Target for Acute Kidney Injury.
Li N; Lin G; Zhang H; Sun J; Gui M; Liu Y; Li W; Liu J; Tang J
Biomolecules; 2022 Jul; 12(7):. PubMed ID: 35883540
[TBL] [Abstract][Full Text] [Related]
16. Intervention of mitochondrial activity attenuates cisplatin-induced acute kidney injury.
Yang Y; Fu Y; Wang P; Liu S; Sha Y; Zhang Y; Zhang A; Jia Z; Ding G; Huang S
Int Urol Nephrol; 2019 Jul; 51(7):1207-1218. PubMed ID: 31020626
[TBL] [Abstract][Full Text] [Related]
17. Chemical inhibition of Src family kinases affects major LPS-activated pathways in primary human macrophages.
Smolinska MJ; Horwood NJ; Page TH; Smallie T; Foxwell BM
Mol Immunol; 2008 Feb; 45(4):990-1000. PubMed ID: 17875324
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the Src and Jak kinases protects against lipopolysaccharide-induced acute lung injury.
Severgnini M; Takahashi S; Tu P; Perides G; Homer RJ; Jhung JW; Bhavsar D; Cochran BH; Simon AR
Am J Respir Crit Care Med; 2005 Apr; 171(8):858-67. PubMed ID: 15665321
[TBL] [Abstract][Full Text] [Related]
19. Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis.
Tabariès S; Annis MG; Hsu BE; Tam CE; Savage P; Park M; Siegel PM
Oncotarget; 2015 Apr; 6(11):9476-87. PubMed ID: 25823815
[TBL] [Abstract][Full Text] [Related]
20. UCP2 alleviates tubular epithelial cell apoptosis in lipopolysaccharide-induced acute kidney injury by decreasing ROS production.
Zhong X; He J; Zhang X; Li C; Tian X; Xia W; Gan H; Xia Y
Biomed Pharmacother; 2019 Jul; 115():108914. PubMed ID: 31071510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
